Does NT-proBNP level predict long-term mortality in patients after ischemic stroke?
Increased NT-proBNP levels identify a vulnerable subgroup of ischemic stroke patients at higher risk for long-term mortality, warranting early cardiovascular assessment.
NT-proBNP represents the most relevant routine blood-based biomarker for the prediction of long-term mortality after ischemic stroke. Increased NT-proBNP levels indicate a vulnerable subgroup of stroke patients in which early and thorough cardiovascular assessment and consistent follow-ups could improve outcome after stroke.
Hatab et al. (Fri,) studied this question.